arrow
P

Paul A. James

The Royal Melbourne Hospital
H指数:70
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The co-design, development, and preliminary evaluation of a comprehensive breast cancer risk report incorporating polygenic risk information

多基因风险信息整合的乳腺癌全面风险评估报告的协同设计、开发与初步评估

2026-07-310
OA
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes

BRCA1-、BRCA2-和PALB2相关的范可尼贫血:扩展疾病表型特征并预测杂合子乳腺癌风险的潜力

2025-10-300
PRE
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

大规模元分析和精确功能测定识别出FANCM区域,其中致病性体细胞突变(PTVs)对ER阴性和三阴性乳腺癌产生不同的风险。

2025-10-300
OAAI
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

一种基于贝叶斯定量分析的基因特异性变异分类方法:更新的专家小组建议改进了TP53生殖细胞变异在Li-Fraumeni综合征中的分类

2025-10-240
OAAI
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

RAD51C、RAD51D和BRIP1基因杂合性胚系致病性变异携带者的管理:美国医学遗传学与基因组学学院(ACMG)的临床实践资源

2025-10-070
PRE
Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations

基于临床-公共卫生效用的主流肿瘤学中乳腺癌胚系多基因-panel检测:ESMO精准肿瘤学工作组建议

2025-06-150
PREAI
Cohort Profile: Lifepool

队列概况:Lifepool

2025-04-170
OA
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

ATM杂合性胚系致病性变异个体的管理:美国医学遗传学与基因组学学院(ACMG)的临床实践资源

2025-01-011
PRE
The 66th ASH Annual Meeting Abstracts POSTER ABSTRACTS

第66届ASH年会摘要 海报摘要

BLOOD
IF23.1
2024-11-050
PRE